Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Cardiovasc Pharmacol. 2013 Jan;61(1):17–22. doi: 10.1097/FJC.0b013e318274d2ef

Figure 4.

Figure 4

Representative images of fibronectin (FN) immunostaining in renal tubular area (stained dark brown). Sham (A) and streptozotocin-induced diabetic rats treated with vehicle (B), amlodipine (C) or aliskiren (D) individually and combined (E). FN immunostaining was increased in vehicle treated diabetic rats, reduced with aliskiren alone or combined with amlodipine and not affected by amlodipine alone treatment. x200 magnification.